How Federal Prosecutors Use Prescription Data Against Physicians
Federal prosecutors use prescription data to identify outliers, then build a narrative around the numbers, and outlier status is not the same as criminal intent. Chapman, Dowling & Mallek spend their early work on the gap between the two.
What Data Sets Does a DOJ Physician Prescription Audit Pull?
A DOJ physician prescription audit rarely begins with a patient complaint. The Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) assemble a profile from several sources at once:
- State prescription drug monitoring program (PDMP) dispensing records
- Medicare Part D and Medicaid pharmacy claims
- DEA registrant ordering and distributor reports
- Pharmacy refusal reports and patient travel distance data
The first screening starts with prescribing volume. Prescribers in the highest percentile for morphine milligram equivalents (MME) get flagged automatically, whether the panel is a hospice census, a cancer center, or a referral-only pain practice.
Where the Government’s Algorithms Break Down
PDMP data mining algorithms are built for population screening, not individual adjudication, and Michigan law says so directly. Under MCL 333.7333a, law enforcement officers, officers of the court, and regulatory agencies using Michigan Automated Prescription System data for investigative or prosecution purposes must consider the nature of the prescriber’s practice and the condition being treated.
That instruction is written into the same statute that created the database, and it gives Michigan prescribers a state-law argument that physicians in most other states simply do not have.
Can Prescription Monitoring Data Be Challenged in Court?
Yes, and on several grounds at once. Agents frequently obtain bulk prescription drug monitoring program records by administrative demand rather than by warrant, which puts a Fourth Amendment question in play over medical information patients assumed would stay with their pharmacy.
A defense also gets traction from gaps in the chain of custody, from data pulls that omitted whole categories of patients, and from a date range the analyst chose for reasons the government has to explain.
What Is the Anatomy of the Government’s Trial Chart?
By trial, years of dispensing data get compressed into a handful of exhibits designed to look damning at a glance. Taking those charts apart is ordinary defense work when a federal target letter prescribing practices notice arrives early enough:
- Ask what patients the analyst excluded and why
- Recalculate the same figures across a full calendar year
- Put cash-pay and insured patients on separate lines
- Compare the prescriber to the referral pattern, not the state average
Automated red flags in prescribing can be challenged with a closer review of patient diagnoses. Once a defense analyst adds that context, the same chart may show a practice treating patients that other clinics turned away.
Put Data Analysts on Your Side of the Case
Our team pairs defense counsel with former federal investigators and data analysts who read these files the way the government does. Chapman, Dowling & Mallek serves prescribers from its Detroit office and in federal courts across the country, and free consultations are available. Call or text (346) 242-7626 or get in touch with our team online today.